Hypothetical Drug Binding Receptor Site Analysis Using CoMFA Method for 3-Arylisoquinolines Active against SK-OV-3 Tumor Cell Line |
김의기
(전남대학교 약학대학)
민선영 (전남대학교 약학대학) 정병호 (전남대학교 약학대학) 천승훈 (전남대학교 약학대학) 최보길 (전남대학교 약학대학) 조원제 (전남대학교 약학대학) |
1 | Rubinstein, L. V., Shoemaker, R. H., Paull, K D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., and Boyd, M. R., J. Natl. Cancer Inst. 82,1113 (1990) |
2 | Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch H, Kenney, S., and Boyd, M. R., J. Natl Cancer Inst. 82, 1107 (1990). DOI |
3 | Raghavan, K., Buolamwini, J. K. Fesen, M. R. Pommier, Y., Kohn, K. W., and Weinstein, J. N., J. Med. Chem. 38, 890 (1995) |
4 | The Sybyl program (Version 6.3) was supplied by Tripos Associates, 1699 South Hanley Road, Suite 303, St. Louis, Missouri 63144, USA |
5 | Kim, K E., Cho, W. J., Chang, S. J., Yong, C. S., Lee, C. H., Kim, D. D. Int. J, Pharmaceutics 217, 101 (2001) |
6 | Cho, W. J., Yoo, S. J., Chung, B. H., Cheon, S. H., Whang, S. H., Kim, S. K, Kang, B. H., Lee, C. O., Arch. Pharm. Res. 19, 321 (1996) |
7 | Cramer, R D. III, Patterson, D. E., Bunce, J. D., J. Am. Chem. Soc. 110, 5959 (1988) |
8 | Mackay, S. P., Meth-Cohn, O. and Waich, R. D. : Advances in Heterocyclic Chemistry, Katritzky, A. R., Editor. Academic Press, p. 345 (1997) |
9 | Cho, W. J., Park, M.J., Chung, B. H., Lee, C. O., Bioorg. & Med. Chem. Lett. 8, 41 (1998) |
10 | Cho, W. J., Yoo, S. J., Park, M. J., Chung, B. H., Lee, C. O., Arch. Pharm. Res. 20, 264 (1997) DOI |
11 | Cho, W. J., Kim, E. K, Park, M. J., Choi, S. D., Lee, C. O., Cheon, S. H., Choi, B. G. and Chung, B. H., Bioorg. & Med. Chem. 6, 2449 (1998) |